SCHEMBL3352182

SCHEMBL3352182

Nn1c(S)nnc1-c1ccccc1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.72
ALDH1A1 P00352 3/20 0.55
HSD17B10 Q99714 3/20 0.44
TXN P10599 1/20 0.43
BRD4 O60885 1/20 0.41
ADORA3 P0DMS8 1/20 0.41
ADORA2A P29274 1/20 0.41
ADORA2B P29275 1/20 0.41
ADORA1 P30542 1/20 0.41
CREBBP Q92793 1/20 0.41
LMNA P02545 2/20 0.40
GAA P10253 1/20 0.39
HPGD P15428 1/20 0.39
TSHR P16473 2/20 0.39
AVPR1A P37288 1/20 0.39
THRB P10828 1/20 0.38
POLB P06746 1/20 0.38
MAPT P10636 1/20 0.38
ALOX15 P16050 1/20 0.38
NPC1 O15118 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12841647 0.84 KMT2A (1.00) KMT2AALDH1A1HSD17B10TXNBRD4
SCHEMBL1164883 0.82 KMT2A (0.47) KMT2AALDH1A1LMNAHPGDMAPT
SCHEMBL1065240 0.82 HPGD (0.47) KMT2AALDH1A1LMNAGAAHPGD
SCHEMBL28578532 0.81 KMT2A (0.49) KMT2AALDH1A1HSD17B10LMNAGAA
SCHEMBL3996167 0.81 ALDH1A1 (0.49) KMT2AALDH1A1HSD17B10LMNAGAA
SCHEMBL16675457 0.80 KMT2A (0.45) KMT2AALDH1A1HSD17B10LMNAGAA
SCHEMBL29315637 0.80 KMT2A (0.45) KMT2AALDH1A1HSD17B10GAAHPGD
SCHEMBL4349728 0.80 KMT2A (0.45) KMT2AALDH1A1HSD17B10LMNAHPGD
SCHEMBL19328339 0.80 KMT2A (0.45) KMT2AALDH1A1ADORA2AADORA1HPGD
SCHEMBL29372146 0.78 NPC1 (0.51) KMT2AALDH1A1ADORA2AADORA1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 126 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114779578-B Photosensitive resin for no-treatment CTP plate and preparation method thereof 安徽强邦新材料股份有限公司 2024-09-27 CN claimed
CN-116239759-A Conjugated two-dimensional polymer film and preparation method and application thereof 中国科学院宁波材料技术与工程研究所 2023-06-09 CN claimed
CN-114779578-A Photosensitive resin for treatment-free CTP plate and preparation method thereof 安徽强邦新材料股份有限公司 2022-07-22 CN claimed
EP-2014797-A2 Coating composition for interconnection part of electrode and plasma display panel including the same Samsung SDI Co., Ltd. (KR) 2009-01-14 EP claimed
US-20080303439-A1 Coating composition for interconnection part of electrode and plasma display panel including the same SAMSUNG SDI CO., LTD., A CORP. OF THE REPUBLIC OF KOREA (KR) 2008-12-11 US claimed
US-12552914-B2 Substituted thiolate salt melt additives 3M INNOVATIVE PROPERTIES COMPANY (US) 2026-02-17 US disclosed
US-20260035573-A1 SEALANTS FOR INHIBITING CORROSION BOEING CO (US) 2026-02-05 US disclosed
US-12522735-B2 Polymeric agents and compositions for inhibiting corrosion THE BOEING COMPANY (US) 2026-01-13 US disclosed
US-12441894-B2 Compositions for inhibiting corrosion THE BOEING COMPANY (US) 2025-10-14 US disclosed
US-12163054-B2 Soluble corrosion resistant sol-gel THE BOEING COMPANY (US) 2024-12-10 US disclosed
CN-116082365-B 1,2, 4-Triazolo [3,4-b ] -1,3, 4-thiadiazole myricetin compound and preparation method thereof 贵州大学 2024-11-05 CN disclosed
CN-114779578-B Photosensitive resin for no-treatment CTP plate and preparation method thereof 安徽强邦新材料股份有限公司 2024-09-27 CN disclosed
US-4626533-A ANTIBIOTICS BIOGAL GYOGYSZERGYAR (HU) 1986-12-02 US disclosed
EP-0140949-A1 NOVEL CEPHALOSPORIN DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME, THEIR USE IN THERAPY AS ANTIBIOTICS AND A PROCESS FOR THE PREPARATION OF THE NOVEL COMPOUNDS BIOGAL GYOGYSZERGYAR (HU) 1985-05-15 EP disclosed
WO-1984004096-A1 NOVEL CEPHALOSPORIN DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME, THEIR USE IN THERAPY AS ANTIBIOTICS AND A PROCESS FOR THE PREPARATION OF THE NOVEL COMPOUNDS BIOGAL GYOGYSZERGYAR (HU) 1984-10-25 WO disclosed
US-4411905-A Antisecretory 1,2,4-triazole-3-thiols RICHARDSON-MERRELL INC. (US) 1983-10-25 US disclosed
US-4230715-A 1,2,4-Triazole-3-thiols as antisecretory agents RICHARDSON-MERRELL INC. (US) 1980-10-28 US disclosed
US-4230792-A COMPLEXING SILVER WITH THIOL OR THIONE MITSUBISHI PAPER MILLS, LTD. (JP) 1980-10-28 US disclosed
US-3954984-A ANTISECRETRETORY AGENTS, CENTRAL NERVOUS SYSTEM DEPRESSANTS RICHARDSON-MERRELL INC. (US) 1976-05-04 US disclosed
US-3954981-A Triazolocycloalkylhydrothiadiazine derivatives RICHARDSON-MERRELL INC. (US) 1976-05-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260035573-A1 SEALANTS FOR INHIBITING CORROSION EPCAM, SFRP1, FZD7 KMT2A 595/4885ALDH1A1 2774/4885HSD17B10 4870/4885
US-12552914-B2 Substituted thiolate salt melt additives FRG1, EXOSC4, SCNN1G KMT2A 1772/4885ALDH1A1 3613/4885HSD17B10 3862/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.